CBM - Nomura bearish on Xencor in premarket analyst action February, 22 2019 07:40 AM Cambrex Corporation Alexion Pharmaceuticals (NASDAQ:ALXN) initiated with Neutral rating and $135 (6% upside) price target at Guggenheim. More news on: Alexion Pharmaceuticals, Inc., Dermira, Exelixis, Inc., Healthcare stocks news, Stocks on the move, , Read more ...